Search Results 1091-1100 of 17976 for sickle cell
D. September 17, 2024. More Mayo neuroscience: Brain cells 'crosstalk' and cancer growth; ...
... cells or T-cell engager therapy such as bispecific and trispecific antibodies and the factors that may determine disease progression and treatment response.
This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns of ...
This clinical study further documented lower death and hospitalization rates among those treated with cell therapy. This research is published in Stem Cells ...
Marla Broadfoot, Ph.D. September 17, 2024. More Mayo neuroscience: Brain cells 'crosstalk' ...
Since then, stem cell transplants have become standard treatment for a number of cancers and other blood-related diseases and conditions. On the next Mayo ...
... cell transplant. Adipose-Derived Mesenchymal Stem Cells (AMSCs) For Recurrent Glioblastoma. Jacksonville, Fla. This study aims to evaluate the safety of ...
More Mayo neuroscience: Brain cells 'crosstalk' and cancer growth; Preoperative radiotherapy survival; Rare mutation causes memory loss.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.